Today: 30 April 2026
Unilever PLC stock price ticks higher after Barclays lifts target — what investors watch next
23 January 2026
1 min read

Unilever PLC stock price ticks higher after Barclays lifts target — what investors watch next

London, Jan 23, 2026, 09:26 GMT — Regular session

  • Unilever shares climbed roughly 0.7% in early London trading.
  • Barclays lifted its target price, while Jefferies maintained a Sell rating.
  • Europe’s STOXX 600 fell, with investors holding back ahead of PMI releases and weighing ongoing trade tensions.

Unilever PLC shares climbed 0.7% to roughly 4,849 pence by 0926 GMT, buoyed by new broker notes that kept the spotlight on the consumer goods giant ahead of its upcoming earnings.

This move is key as investors scramble to define what “steady” means for major consumer staples amid a volatile market, where trade headlines and data risks are once again taking center stage.

This comes just before Unilever’s next earnings update, with fourth-quarter and full-year 2025 results set for Feb. 12. The company is also slated to speak at the CAGNY consumer conference on Feb. 17.

Barclays analyst Warren Ackerman stuck with a Buy rating and nudged up his target price to 5,700 pence from 5,500, a broker’s forecast for the stock over the next year, according to a dpa-AFX note on MarketScreener.

Jefferies held its ground, with analyst David Hayes sticking to a Sell rating, according to MarketScreener’s dpa-AFX feed.

European shares edged lower Friday, with the STOXX 600 shedding 0.2%, set to close the week in the red. Investors digested new friction in U.S.-Europe trade over Greenland and braced for upcoming PMI data from both regions.

Unilever’s upcoming earnings report comes on the heels of last month’s restructuring tied to the Magnum ice cream spin-off. That included an 8-for-9 share consolidation, which began trading in early December.

Some investors remain focused on the fallout from that split. On Thursday, Magnum — now overseeing Unilever’s old ice cream unit — accused former Ben & Jerry’s board chair Anuradha Mittal of “serious misconduct,” according to a court filing tied to an ongoing governance dispute at the brand, Reuters reported. Reuters

Still, the boost from broker chatter could evaporate quickly if the numbers come up short. Signs of slowing volume growth, waning pricing power, or rising costs might squeeze the trading range, especially since valuations are already stretched for defensive stocks.

Friday’s PMI numbers will give traders an immediate read on demand before attention turns to Unilever’s Feb. 12 earnings. Investors will be looking closely for clues on margins and how the newly separated business is performing as 2026 approaches.

Stock Market Today

  • SoftBank Targets $100 Billion U.S. IPO for AI Robotics Spinout Roze
    April 30, 2026, 8:37 AM EDT. SoftBank Group plans to spin off Roze, an AI and robotics unit focused on automating server farm construction, aiming for a U.S. IPO valued at about $100 billion. The listing could occur in the second half of 2026, driven by CEO Masayoshi Son. However, internal resistance exists over the valuation and timeline, partly due to geopolitical tensions in the Middle East. Roze's assets might include SoftBank's energy, land, and infrastructure holdings, plus ABB Robotics acquired last year. The IPO proceeds would support Son's large financial commitments, including $30 billion invested in OpenAI. This move ties into the $500 billion Stargate project, a national AI infrastructure initiative. SoftBank's stock has risen over 18% year-to-date.

Latest article

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Gas Prices Hit $4.30: Why America’s Oil Boom Isn’t Saving Drivers

Gas Prices Hit $4.30: Why America’s Oil Boom Isn’t Saving Drivers

30 April 2026
U.S. gasoline prices hit $4.30 a gallon Thursday, the highest since 2022, as the Iran war and refinery issues drove up crude costs. Brent crude briefly topped $126 a barrel before settling at $121.90. U.S. crude output reached a record 13.6 million barrels per day last year, but high exports and falling inventories tightened supplies. Michigan saw prices jump to $4.58 amid regional refinery problems.
Coinbase stock dips after hours as Jan. 27 crypto bill markup looms — and stablecoin rewards stay in focus
Previous Story

Coinbase stock dips after hours as Jan. 27 crypto bill markup looms — and stablecoin rewards stay in focus

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap
Next Story

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Go toTop